Biopharmaceutical firm Zai Lab raises $825m in HK IPO

Biopharmaceutical firm Zai Lab raises $825m in HK IPO

A scientist works in Zai Lab's drug development laboratory in Shanghai in October 2018.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter